The primary objective of this study is to assess the 6-month safety of DBV712 250 micrograms (mcg) in subjects 1 through 3 years of age with peanut allergy.
Age: 1 year - 3 years
Gender: All
We've found 1 total result for "Nut and Peanut Hypersensitivity".
The primary objective of this study is to assess the 6-month safety of DBV712 250 micrograms (mcg) in subjects 1 through 3 years of age with peanut allergy.
Age: 1 year - 3 years
Gender: All